New HIV prevention technologies (NPTs) can be a critical part of comprehensive HIV prevention. In the Canadian context, NPTs are generally understood to include vaginal and rectal microbicides, post-exposure prophylaxis (PEP), pre-exposure prophylaxis (PrEP), treatment-as-prevention (TaP) and vaccines. On September 15-16, 2011, four Canadian NGOs (Canadian AIDS Society, CATIE, Interagency Coalition on AIDS and Development, and the Canadian Public Health Association) collaborated, with financial support from the Canadian Institutes of Health Research, to host a national stakeholder meeting in Ottawa. The purpose of the meeting was to engage Canadian stakeholders in identifying implementation issues for NPTs, and based on these, identify research needs and priorities that provide a research agenda for social, clinical and policy researchers. Representatives from relevant stakeholder groups (policy-makers, community representatives, researchers, public health and the private sector) participated in the working meeting to identify the knowledge gaps which should be filled for effective policy and programming decisions to be made in Canada, and to ensure that Canadian stakeholders are appropriately prepared for the introduction of NPTs in Canada. In advance of the working meeting, the four national NGOs produced a draft of this Framework Document to outline the regulatory, policy and programming barriers and issues that they identified as needing to be addressed, as well as research questions, needs and priorities that they believed should be pursued, related to the introduction of NPTs in the Canadian context. Subsequently (after the meeting), the project partners and relevant stakeholders incorporated the input given by participants in the working meeting into the framework document, and intend for this Framework Document to be used as a basis for continued NPT preparedness work for Canada.
- Pages
- 15
- Published in
- Ottawa, Ontario
